A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy.
- DOI
- 10.1093/jimmun/vkaf016
- Published
- 2025-06-01
- Container
- J Immunol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/jimmun/vkaf016,
title = {A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy.},
author = {George MM and Brennick CA and Hagymasi AT and Shcheglova TV and Al Seesi S and Rosales TJ and Baker BM and Mandoiu II and Srivastava PK.},
year = {2025},
journal = {J Immunol},
doi = {10.1093/jimmun/vkaf016},
url = {https://doi.org/10.1093/jimmun/vkaf016}
}RIS
TY - JOUR TI - A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy. AU - George MM AU - Brennick CA AU - Hagymasi AT AU - Shcheglova TV AU - Al Seesi S AU - Rosales TJ AU - Baker BM AU - Mandoiu II AU - Srivastava PK. PY - 2025 JO - J Immunol DO - 10.1093/jimmun/vkaf016 UR - https://doi.org/10.1093/jimmun/vkaf016 ER -
APA
MM, G., CA, B., AT, H., TV, S., S, A. S., TJ, R., BM, B., II, M., & PK., S. (2025). A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy.. J Immunol. https://doi.org/10.1093/jimmun/vkaf016
Source records
- europe-pmc · retrieved 2026-09-26T22:35:24.253Z